Recombinant Human CXCL3/CINC-2α/β Protein(Trx Tag)

Recombinant Human CXCL3/CINC-2α/β Protein(Trx Tag)
Artikelnummer
ELSPDEH100600-1
Verpackungseinheit
1mg
Hersteller
Elabscience Biotechnology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Protein Tag: N-Trx

Uniprot: P19876

Accession: P19876

Background: CXCL3/CINC-2α/β is involved in migration, invasion, proliferation and tubule formation of trophoblasts and may play a key role in the pathogenesis of preeclampsia. CXCL3/CINC-2α/β autocrine/paracrine pathways are involved in the development of prostate cancer by regulating the expression of the target genes that are related to the progression of malignancies. CXCL3/CINC-2α/β is a novel adipokine that facilitates adipogenesis in an autocrine and/or a paracrine manner throμgh induction of c/ebpb and c/ebpd. CXCL3/CINC-2α/β and its receptor CXCR2 are overexpressed in prostate cancer cells, prostate epithelial cells and prostate cancer tissues, which may play multiple roles in prostate cancer progression and metastasis.

Bio Acitivity: Not validated for activity

Sequence: Cys35-Phe107

Purity: > 90% as determined by reducing SDS-PAGE.

Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with 5% Trehalose and 5% Mannitol.

Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis.

Endotoxin: < 10 EU/mg of the protein as determined by the LAL method.

Calculated MW: 27.9 kDa

Observed MW: 30 kDa
Mehr Informationen
Artikelnummer ELSPDEH100600-1
Hersteller Elabscience Biotechnology
Hersteller Artikelnummer PDEH100600-1
Verpackungseinheit 1mg
Mengeneinheit STK
Reaktivität Human
Wirt Escherichia Coli
Produktinformation (PDF)
×
MSDS (PDF)
×